The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 17, Issue 5, Pages 525-535
Publisher
Informa UK Limited
Online
2018-04-18
DOI
10.1080/14740338.2018.1462335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors
- (2018) Matthew R. Weir et al. AMERICAN JOURNAL OF MEDICINE
- Associations of serum potassium levels with mortality in chronic heart failure patients
- (2017) Mette Aldahl et al. EUROPEAN HEART JOURNAL
- Serum potassium in patients with chronic heart failure: once we make a U-turn where should we go?
- (2017) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study
- (2017) W. Ouwerkerk et al. EUROPEAN HEART JOURNAL
- Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers
- (2017) Lawrence J. Lesko et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- TO028EFFECT OF PATIROMER ON SERUM POTASSIUM IN HYPERKALEMIC PATIENTS WITH SEVERE CKD ON RAAS INHIBITORS: RESULTS FROM OPAL-HK AND AMETHYST-DN
- (2017) David Bushinsky et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study
- (2017) Morten Schmidt et al. BMJ Open
- Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis
- (2016) David A. Bushinsky et al. AMERICAN JOURNAL OF NEPHROLOGY
- Effect of Patiromer on Urinary Ion Excretion in Healthy Adults
- (2016) David A. Bushinsky et al. Clinical Journal of the American Society of Nephrology
- 10. Microvascular Complications and Foot Care
- (2016) DIABETES CARE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer
- (2016) Murray Epstein et al. EXPERT OPINION ON PHARMACOTHERAPY
- Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia
- (2016) Lingyun Li et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2016) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors
- (2016) Matthew R. Weir et al. KIDNEY INTERNATIONAL
- Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors
- (2015) Bertram Pitt et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
- (2015) David A. Bushinsky et al. KIDNEY INTERNATIONAL
- Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
- (2015) Matthew R. Weir et al. NEW ENGLAND JOURNAL OF MEDICINE
- KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
- (2014) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Characterization of Structure and Function of ZS-9, a K+ Selective Ion Trap
- (2014) Fiona Stavros et al. PLoS One
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
- (2011) B. Pitt et al. EUROPEAN HEART JOURNAL
- The Phosphate Binder Equivalent Dose
- (2011) John T. Daugirdas et al. SEMINARS IN DIALYSIS
- Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors
- (2010) M. R. Weir et al. Clinical Journal of the American Society of Nephrology
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
- (2010) A. Catharine Ross et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
- (2009) Lisa M. Einhorn et al. ARCHIVES OF INTERNAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation